Case Studies

IRStrategy

Investor Relations: R&D Day

Global, Clinical, Public

Newron Pharmaceuticals SpA: Expanded Global and U.S. Investor Visibility

Newron is a Swiss-traded biopharmaceutical company focused on late-stage clinical therapies for patients with diseases of the central nervous system. Newron was looking to provide investors a further understanding of their investment thesis, build their visibility globally, and in particular, expand their presence within the US investment, sell-side analyst and investment banking community.

LHS Solution

  • Execute a globally viewed scientific and investor-oriented R&D Day to increase investor visibility.
  • Develop a US-centric marketing strategy for the event, including message and presentation development, event and location branding and broadcast design.
  • Audience acquisition through extensive media relations, press release distribution, focused email campaigns and personal investor outreach.

Results

  • Secured the participation of two of the world’s leading KOLs in Rett syndrome and Schizophrenia as speakers.
  • More than 850 webcast participants from 7 countries worldwide.
  • 35 in-person attendees, including representatives from 8 investment banks and 9 sell-side analysts.
  • Extensive media coverage including CheckRare.com live video of KOL Daniel Glaze, MD, of Baylor College of Medicine discussing the state of Rett syndrome treatment.

Partner with us to build your winning company

Our experienced, multi-disciplined team provides seamless integrated communications, offering strategy consulting, investor and corporate communications and public relations/marketing.